SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $639,000 | -56.4% | 26,940 | -49.5% | 0.04% | -47.1% |
| Q3 2019 | $1,466,000 | -48.1% | 53,345 | -37.5% | 0.07% | -44.4% |
| Q2 2019 | $2,823,000 | -6.2% | 85,320 | -0.7% | 0.13% | +8.6% |
| Q1 2019 | $3,011,000 | +5.5% | 85,935 | 0.0% | 0.12% | +0.9% |
| Q4 2018 | $2,855,000 | -36.5% | 85,935 | -3.8% | 0.12% | -12.9% |
| Q3 2018 | $4,497,000 | -13.0% | 89,305 | +3.4% | 0.13% | -16.5% |
| Q2 2018 | $5,167,000 | – | 86,340 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |